Global SARS-CoV-2 genomic surveillance: What we have learned (so far)

Alcantara, 2022, SARS-CoV-2 epidemic in Brazil: how the displacement of variants has driven distinct epidemic waves, Virus Res., 2, 198 Andrews, 2022, Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England, Nat. Med., 28, 10.1038/s41591-022-01699-1 Barouch, D. H. (2022). Covid-19 VaccinesBashor, L. Gagne, R. B. Bosco-Lauth, A. M. Bowen, R. A. Stenglein, VandeWoude, M. S. (2021) SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection. Proc. Natl. Acad. Sci., 118(44), e2105253118. doi:https://doi.org/10.1073/pnas.2105253118. Barrett, 2022, The rapid progress in COVID vaccine development and implementation, Npj Vaccines, 7, 10.1038/s41541-022-00442-8 Bedford, 2020, COVID-19: towards controlling a pandemic, Lancet, 395, 1015, 10.1016/S0140-6736(20)30673-5 Bienzle, 2022, Risk Factors for SARS-CoV-2 Infection and Illness in Cats and Dogs, Emerg. Infect. Dis., 28, 1154, 10.3201/eid2806.220423 Boehm, 2021, Novel SARS-CoV-2 variants: the pandemics within the pandemic, Clin. Microbiol. Infect., 27, 1109, 10.1016/j.cmi.2021.05.022 Boyton, 2021, The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?, Nat. Rev. Immunol., 21, 762, 10.1038/s41577-021-00631-x Brito, 2022, Global disparities in SARS-CoV-2 genomic surveillance, Nat. Commun., 13, 7003, 10.1038/s41467-022-33713-y Chen, 2021, A cross-country comparison of fiscal policy responses to the COVID-19 global pandemic, J. Comparat. Policy Anal.: Res. Pract., 23, 262 Cherian, 2021, SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India, Microorganisms, 9, 1542, 10.3390/microorganisms9071542 Chu, 2015, Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, Eurosurveillance, 20, 30086, 10.2807/1560-7917.ES.2015.20.49.30086 Cucinotta, 2020, WHO declares COVID-19 a pandemic, Acta Bio-Med.: Atenei Parmensis, 91, 157 Dudas, 2018, MERS-CoV spillover at the camel-human interface, Elife, 16 Eraslan, 2019, Deep learning: new computational modelling techniques for genomics, Nat. Rev. Genet., 20, 389, 10.1038/s41576-019-0122-6 Fagre, 2021, SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: implications for spillback to New World rodents, PLoS Pathog., 17, 10.1371/journal.ppat.1009585 Faria, 2021, Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil, Science, 372, 815, 10.1126/science.abh2644 Focosi, 2022, Recombination in coronaviruses, with a focus on SARS-CoV-2, Viruses, 14, 10.3390/v14061239 Galloway, 2021, Emergence of SARS-CoV-2 B.1.1.7 Lineage—United States, December 29, 2020–January 12, 2021, MMWR Morb. Mortal. Wkly Rep., 70, 10.15585/mmwr.mm7003e2 Geidelberg, 2021, Genomic epidemiology of a densely sampled COVID-19 outbreak in China, Virus Evol., 7, 10.1093/ve/veaa102 Giovanetti, 2022, Genomic epidemiology of the SARS-CoV-2 epidemic in Brazil, Nat. Microbiol., 7, 1490, 10.1038/s41564-022-01191-z Giovanetti, 2022, Replacement of the gamma by the Delta variant in Brazil: impact of lineage displacement on the ongoing pandemic, Virus Evol., 8, 10.1093/ve/veac024 Hale, 2022, SARS-CoV-2 infection in free-ranging white-tailed deer, Nature, 602, 481, 10.1038/s41586-021-04353-x Haug, 2020, Ranking the effectiveness of worldwide COVID-19 government interventions, Nat. Hum. Behav., 4, 10.1038/s41562-020-01009-0 Heinz, 2021, Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action, Npj Vaccines, 6, 10.1038/s41541-021-00369-6 Hill, 2021, Progress and challenges in virus genomic epidemiology, Trends Parasitol., 37, 1038, 10.1016/j.pt.2021.08.007 Hoang, 2022, AusTrakka: fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic, Nat. Commun., 13, 10.1038/s41467-022-28529-9 Hoofman, 2021, The effect of COVID-19 on education, Pediatr. Clin. N. Am., 68, 1071, 10.1016/j.pcl.2021.05.009 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet (London, England), 395, 497, 10.1016/S0140-6736(20)30183-5 Jelinek, 2021, Evolution, ecology, and zoonotic transmission of Betacoronaviruses: a review, Front. Vet. Sci., 8, 10.3389/fvets.2021.644414 Khare, 2021, GISAID’s role in pandemic response, China CDC Weekly, 3, 1049, 10.46234/ccdcw2021.255 Korber, 2020, Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus, Cell, 182, 812, 10.1016/j.cell.2020.06.043 Larsen, 2021, Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020, Eurosurveillance, 26, 10.2807/1560-7917.ES.2021.26.5.210009 Lytras, 2022, Exploring the natural origins of SARS-CoV-2 in the light of recombination, Genome Biol. Evol., 14, 10.1093/gbe/evac018 Mardian, 2021, Review of current COVID-19 diagnostics and opportunities for further development, Front. Med., 8, 10.3389/fmed.2021.615099 Marjanovic, 2022, COVID-19 genomics UK (COG-UK) consortium: final report, Rand Health Quart., 9, 24 Mathieu, 2020 Msomi, 2020, A genomics network established to respond rapidly to public health threats in South Africa, The Lancet Microbe., 1, e229, 10.1016/S2666-5247(20)30116-6 Nonaka, 2021, Genomic evidence of SARS-CoV-2 reinfection involving E484K spike mutation, Brazil, Emerg. Infect. Dis., 27, 1522, 10.3201/eid2705.210191 Oran, 2021, The proportion of SARS-CoV-2 infections that are asymptomatic: A systematic review, Ann. Intern. Med., 174, 655, 10.7326/M20-6976 Oude Munnink, 2021, The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology, Nat. Med., 27, 10.1038/s41591-021-01472-w Pekar, 2022, The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2, Science, 377, 960, 10.1126/science.abp8337 Plante, 2021, Spike mutation D614G alters SARS-CoV-2 fitness, Nature, 592, 10.1038/s41586-020-2895-3 Pley, 2021, The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection, BMJ Glob. Health, 6, 10.1136/bmjgh-2020-004275 Rambaut, 2020, A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology, Nat. Microbiol., 5, 10.1038/s41564-020-0770-5 Sadarangani, 2021, Immunological mechanisms of vaccine-induced protection against COVID-19 in humans, Nat. Rev. Immunol., 21, 475, 10.1038/s41577-021-00578-z Sah, 2021, Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis, Proc. Natl. Acad. Sci. U. S. A., 118, 10.1073/pnas.2109229118 Schindell, 2022, SARS-CoV-2 and the missing link of intermediate hosts in viral emergence—what we can learn from other Betacoronaviruses, Front. Virol., 2, 10.3389/fviro.2022.875213 Sengar, 2022, TMH COVID-19 action group. Outcomes of COVID-19 and risk factors in patients with cancer, Nat. Can., 3, 551 Sharun, 2021, SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications, Vet. Q., 41, 181, 10.1080/01652176.2021.1921311 Sitaras, 2022, Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant, NPJ Vaccines, 7, 147, 10.1038/s41541-022-00565-y Stockdale, 2022, The potential of genomics for infectious disease forecasting, Nat. Microbiol., 7, 10.1038/s41564-022-01233-6 Swets, 2022, SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses, Lancet, 16, 1463, 10.1016/S0140-6736(22)00383-X Tegally, 2021, Detection of a SARS-CoV-2 variant of concern in South Africa, Nature, 592, 10.1038/s41586-021-03402-9 Tegally, 2022, Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa, Nat. Med., 28, 10.1038/s41591-022-01911-2 Tegally, 2022, The evolving SARS-CoV-2 epidemic in Africa: insights from rapidly expanding genomic surveillance, Science, 378, 10.1126/science.abq5358 The White House, 2021 Tuekprakhon, 2022, Antibody escape of SARS-CoV-2 omicron BA.4 and BA.5 from vaccine and BA.1 serum, Cell, 185, 2422, 10.1016/j.cell.2022.06.005 Turakhia, 2022, Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape, Nature, 609, 994, 10.1038/s41586-022-05189-9 Volz, 2021, Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity, Cell, 184, 64, 10.1016/j.cell.2020.11.020 Wang, 2022, Assessing the asymptomatic proportion of SARS-CoV-2 infection with age in China before mass vaccinationJ, R. Soc. Interface., 10.1098/rsif.2022.0498 WHO World Health Organization, 2021 Wu, 2020, A new coronavirus associated with human respiratory disease in China, Nature, 579, 10.1038/s41586-020-2008-3 Yurkovetskiy, 2020, Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant, Cell, 183, 739, 10.1016/j.cell.2020.09.032 Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 10.1038/s41586-020-2012-7 Zuin, 2021, Viral load difference between symptomatic and asymptomatic COVID-19 patients: systematic review and Meta-analysis, Infect. Dis. Rep., 13, 645, 10.3390/idr13030061